Latest Headlines

  1. MilliporeSigma Introduces Comprehensive AAV Express Platform For Streamlined Gene Therapy Production 10/17/2025
  2. 3P Innovation's Fill2Weight Technology Expands High-Precision Filling Capability At The CDMO, Upperton 10/16/2025
  3. Avantor® And BlueWhale Bio Partner To Accelerate CAR-T Manufacturing With Breakthrough Cell Activation And Expansion Technology 10/15/2025

    Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technologies industries, today announced a strategic partnership with BlueWhale Bio, a commercial-stage company dedicated to transforming immune cell therapy manufacturing and addressing the unmet need in CAR-T production by streamlining manufacturing, reducing variability, and shortening time-to-patient.

  4. Biorasi Unveils New Website To Drive Sponsor Success With Biotech-Centric Strategies And Modular CRO Solutions 10/9/2025

    Biorasi has relaunched its website to reflect a bold new direction: Empowering biotech sponsors with modular clinical trial solutions, AI-powered tools, and a renewed focus on sponsor-centric strategy.

  5. RoosterBio And Secretome Therapeutics Announce Successful Completion Of Large Scale Bioreactor Production For Clinical Stage Cell Therapy Candidate STM-01 10/6/2025

    RoosterBio Inc., a leading supplier of human mesenchymal stem/stromal cells (MSCs), highly engineered media, and bioprocess development services, and Secretome Therapeutics, a clinic-stage company developing novel therapies derived from neonatal cardiac progenitor cells (nCPC) today announced completion of commercial scale production of Secretome’s lead nCPC, STM-01.

  6. AAV Producer Cell Lines, A New Standard For Viral Vector Manufacturing 10/6/2025

    Asimov, the synthetic biology company advancing the design and manufacture of therapeutics, today announced the launch of its AAV Edge Stable Producer System. With this launch, Asimov aims to address the shortcomings of traditional transient transfection-based production and bring AAV manufacturing standards closer to those established for antibody-based biologics.

  7. Avance Clinical Accelerates Time To Pivotal Milestones For More Than 700 Emerging Biotechs 9/30/2025

    Avance Clinical, a partner for biotechs providing global contract research organization services, has now guided 710 emerging biotechs through critical clinical trial inflection points.

  8. Avance Clinical Attends Reception Welcoming Australia's US Ambassador To North Carolina Governor's Executive Mansion In Raleigh, N.C. 9/30/2025

    Avance Clinical was honored to attend a special reception at the Executive Mansion in Raleigh, North Carolina, hosted by Governor Josh Stein to welcome His Excellency, The Honorable Kevin Rudd AC, Australia’s Ambassador to the United States.

  9. Avance Clinical Strengthens Korea Focus: Seoul Meeting Highlights Growth, Partnerships, And Regional Collaboration 9/30/2025

    Avance Clinical, a global CRO headquartered in South Australia, met with Mr Jeff Robinson, South Australian Ambassador to Korea, to advance collaboration opportunities between South Australia and Korea in biotech clinical research.

  10. ProBioGen To Lead GMP Manufacturing Operations At Berlin Center For Gene And Cell Therapies (BC GCT) 9/16/2025

    ProBioGen will oversee the design, lead the construction, and subsequently operate the 4,600-square-meter GMP manufacturing unit — an integral part of the center, envisioned as a powerhouse for translational medicine and innovation in Berlin and beyond.